Literature DB >> 1984503

Correlates of survival and the Daumas-Duport grading system for astrocytomas.

T S Kim1, A L Halliday, E T Hedley-Whyte, K Convery.   

Abstract

In order to examine the correlation between prognosis and the histological features of nuclear atypia, mitosis, endothelial proliferation, and necrosis in supratentorial adult astrocytomas, the authors reviewed 251 such cases treated at the Massachusetts General Hospital between 1972 and 1980. One point was given for the presence of each feature. The total number of features was translated into a grade as follows: none of the four features = Grade 1 (one patient), one feature = Grade 2 (36 patients), two features = Grade 3 (33 patients), and three or four features = Grade 4 (181 patients). The period of survival was significantly associated with grade, the presence or absence of each of the four histological features, patient's age, type of operation, radiation therapy, and extent of tumor (log rank, p less than 0.05). The variables associated with grade were age (p less than 0.001) and radiation therapy (p less than 0.02). After adjustment for these variables using a Cox proportional-hazards model, the difference in overall survival time between patients in Grades 2 and 3 was not statistically significant. When comparable groups of patients were examined in terms of age or receipt of radiation therapy, the median survival times differed markedly. Patients 50 years of age or less had a median survival time of 68 months (Grade 2 tumors), 29 months (Grade 3 tumors), and 13 months (Grade 4 tumors). Patients over 50 years of age had a median survival time of 6 months (Grade 2 and 4 tumors) and 9 months (Grade 3 tumors). Those patients who had received radiation therapy had a median survival time of 68 months (Grade 2 tumors), 21 months (Grade 3 tumors), and 11 months (Grade 4 tumors). Those patients who did not receive radiation therapy had a median survival time of 1 month (Grade 2 tumors) and 2 months (Grade 3 and 4 tumors); over half of these patients died within 2 months of surgery. This grading system, originally proposed by Daumas-Duport, et al., is simple, objective, and reproducible, and correlates well with survival times. The authors recommend that astrocytomas be graded on a scale of 1 to 4, with Grade 1 reserved for the rare adult supratentorial astrocytoma with none of the four histological features.

Entities:  

Mesh:

Year:  1991        PMID: 1984503     DOI: 10.3171/jns.1991.74.1.0027

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  26 in total

Review 1.  Brain tumor clinical trials: pitfalls and promise for the future.

Authors:  M R Gilbert
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

2.  A comparative survival evaluation and assessment of interclassification concordance in adult supratentorial astrocytic tumors.

Authors:  A K Karak; R Singh; P N Tandon; C Sarkar
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Cancer treatment - objectives and quality of life issues.

Authors:  Farhat Aziz Khan; Shad Salim Akhtar; Muhammad Kamil Sheikh
Journal:  Malays J Med Sci       Date:  2005-01

4.  Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.

Authors:  Manila Antonelli; Francesca Romana Buttarelli; Antonietta Arcella; Sumihito Nobusawa; Vittoria Donofrio; Hiroko Oghaki; Felice Giangaspero
Journal:  J Neurooncol       Date:  2010-02-21       Impact factor: 4.130

Review 5.  RNA interference and nonviral targeted gene therapy of experimental brain cancer.

Authors:  Ruben J Boado
Journal:  NeuroRx       Date:  2005-01

6.  Supratentorial gliomas: a comparative study by grade and histologic type.

Authors:  E G Shaw; B W Scheithauer; J R O'Fallon
Journal:  J Neurooncol       Date:  1997-02       Impact factor: 4.130

7.  Prospective evaluation of a prognostic index for intrinsic supratentorial tumours.

Authors:  E T Hedley-Whyte
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

8.  Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.

Authors:  R Chambers; G Y Gillespie; L Soroceanu; S Andreansky; S Chatterjee; J Chou; B Roizman; R J Whitley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.

Authors:  Kazuyuki Kuwayama; Kazuhito Matsuzaki; Yoshihumi Mizobuchi; Hideo Mure; Keiko T Kitazato; Teruyoshi Kageji; Mitsuyoshi Nakao; Shinji Nagahiro
Journal:  Neuro Oncol       Date:  2008-09-23       Impact factor: 12.300

10.  Supratentorial glioblastoma: neuroradiological findings and survival after surgery and radiotherapy.

Authors:  A Pierallini; M Bonamini; M F Osti; P Pantano; F Palmeggiani; A Santoro; R Maurizi Enrici; L Bozzao
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.